Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
The nutrient-dependent glucagon-like peptide-1 (7-36) amide (GLP-1) release was studied in comparison to the glucose-dependent insulin-releasing polypeptide (GIP) response in 10 healthy volunteers each undergoing various protocols. Plasma samples were saved up to 120 min after challenges by oral, intravenous or intraduodenal administration of nutrients. Basal plasma-GLP-1 concentrations ranged between 0.4 and 1.4 pM, maximal postprandial GLP-1 levels peaked between 10 and 12 pM. Intravenous glucose (25 g i.v.) did not change basal GLP-1 levels. Oral administration of glucose (50 g) induced a biphasic GLP-1 release peaking at 30-60 min and a biphasic GIP release peaking at 5 and 45 min. This increase paralleled the secretion of insulin. Oral galactose (100 g) and amino acids (25 g) also induced a rapid plasma GLP-1 response. After fat (67 g corn oil) a strong and long-lasting (> 120 min) increase of GLP-1 plasma levels occurred. When a mixed liquid meal was given (6 g soybean oil, 5 g casein, 13 g glucose) immunoreactive (IR)-GLP-1 rapidly increased and peaked after 5 min with declining levels after 30 min. In response to an intraduodenal infusion of a small glucose load (5.34 g within 120 min) a rapid, short-lasting GLP-1 response occurred whereas plasma GIP and insulin levels remained unaltered. Luminal perfusion of an isolated vascularly perfused rat ileum with a polydiet induced a rapid rise of portally released IR-GLP-1 which was followed by a sustained release. Glucose e…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these hormones, the most studied are the incretin hormones like GLP-1 and GIP that are secreted mainly by the intestine in response to a meal [7] (Figure 1).”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [7]
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 613
Harris, K. F. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz040 · Cited by 58
Glucagon-Like Peptide-1 and Energy Homeostasis3
Burcelin, R., Cani, P. D., & Knauf, C. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2534s · Cited by 66
Adam, T. C. M., Lejeune, M. P. G. M., & Westerterp-Plantenga, M. S. (2006) · British Journal of Nutrition · doi:10.1079/bjn20051614 · Cited by 54
He, M., Su, H., Gao, W., Johansson, S. M., Liu, Q., Wu, X., Liao, J., Young, A. A., Bartfai, T., & Wang, M.-W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014205 · Cited by 56
Ahren, B., Larsson, H., & Holst, J. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370127 · Cited by 55
Soengas, J. L., & Moon, T. W. (1998) · Journal of Experimental Biology · doi:10.1242/jeb.201.23.3263 · Cited by 53
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
Peters, C. T., Choi, Y.-H., Brubaker, P. L., & Anderson, G. H. (2001) · Journal of Nutrition · doi:10.1093/jn/131.8.2164 · Cited by 59
Khoo, C. M., Muehlbauer, M. J., Stevens, R. D., Pamuklar, Z. N., Chen, J., Newgard, C. B., & Torquati, A. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e318296633f · Cited by 56
Aziz, A. A., & Anderson, G. H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2326 · Cited by 57
Nutritional Health Considerations for Persons with Spinal Cord Injury
Bigford, G. E., & Nash, M. S. (2017) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci2303-188 · Cited by 55
Lu, W. J., Yang, Q., Yang, L., Lee, D., D’Alessio, D., & Tso, P. (2012) · Lipids · doi:10.1007/s11745-011-3650-1 · Cited by 52
Ang, M., & Linn, T. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076638 · Cited by 52
Dardevet, D., Moore, M. C., DiCostanzo, C. A., Farmer, B., Neal, D. W., Snead, W., Lautz, M., & Cherrington, A. D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2005 · Cited by 48
Brennan, I. M., Little, T. J., Feltrin, K. L., Smout, A. J. P. M., Wishart, J. M., Horowitz, M., & Feinle-Bisset, C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90791.2008 · Cited by 45
Brynes, A. E., EDWARDS, C. M. B., Jadhav, A., Ghatei, M. A., Bloom, S. R., & Frost, G. S. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1111 · Cited by 48
Rhee, N. A., Vilsbøll, T., & Knop, F. K. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01505.x · Cited by 47
“Carbohydrate, protein and fat in the lumen of the small intestine stimulate the L cells to release GLP-1 into the circulation where it induces insulin secretion in the pancreas [38].”
BackgroundAnorexia of Aging and Gut Hormones
Atalayer, D., & Astbury, N. M. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400264 · Cited by 50
Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis
Flatt, P., Bailey, C., & Green, B. (2009) · Current Drug Metabolism · doi:10.2174/138920009787522124 · Cited by 46
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease
Wolfe, M. M., Boylan, M. O., & Chin, W. W. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf006 · Cited by 48
Terry, N. A., Walp, E. R., Lee, R. A., Kaestner, K. H., & May, C. L. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00390.2013 · Cited by 47
Knezović, A., Barilar, J. O., Perhoč, A. B., Bagarić, R., Farkaš, V., Riederer, P. F., & Šalković‐Petrišić, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.027 · Cited by 49
Novel insight into the distribution of L-cells in the rat intestinal tract.
Hansen, C. F., Vrang, N., Sangild, P. T., & Jelsing, J. (2013) · Europe PMC (PubMed Central) · Cited by 60
García-Gutiérrez, E., O’Mahony, A. K., dos Santos, R. S., Marroquí, L., & Cotter, P. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2401654 · Cited by 52
Koole, C., Savage, E. E., Christopoulos, A., Miller, L. J., Sexton, P. M., & Wootten, D. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1116 · Cited by 42
Little, T. J., & Feinle-Bisset, C. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00178 · Cited by 47
Physiology of energy homeostasis: Models, actors, challenges and the glucoadipostatic loop
Chapelot, D., & Charlot, K. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.012 · Cited by 46
O'Harte, F. P. M., Mooney, M. H., Lawlor, A., & Flatt, P. R. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00214-7 · Cited by 47
An update on the islet renin–angiotensin system
Cheng, Q., & Leung, P. S. (2011) · Peptides · doi:10.1016/j.peptides.2011.03.003 · Cited by 45
The role of gut hormones in appetite regulation (review)
Maric, G. D., Gazibara, T. M., Zaletel, I. V., Labudović‐Borović, M., Tomanović, N., Ćirić, M., & Puškaš, N. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.4.1 · Cited by 56
Xie, Z., Jiang, H., Liu, W., Zhang, X., Chen, D., Sun, S.-M., Zhou, C., Liu, J., Bao, S., Wang, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02974-0 · Cited by 42
Idorn, T., Knop, F. K., Jørgensen, M. B., Christensen, M., Holst, J. J., Hornum, M., & Feldt-Rasmussen, B. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3809 · Cited by 41
Green, B. D., Gault, V. A., Mooney, M. H., Irwin, N., Harriott, P., Greer, B., Bailey, C. J., O'Harte, F. P. M., & Flatt, P. R. (2004) · Biological Chemistry · doi:10.1515/bc.2004.035 · Cited by 42
Macronutrients and obesity: Revisiting the calories in, calories out framework
Riera‐Crichton, D., & Tefft, N. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2014.04.002 · Cited by 47
Xanthakos, S. A. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.04.005 · Cited by 45
Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review
Watkins, J. D., Koumanov, F., & Gonzalez, J. T. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab078 · Cited by 40
Holst, J. J., & McGill, M. A. (2011) · Clinical Drug Investigation · doi:10.2165/11595370-000000000-00000 · Cited by 44
Adachi, T., Tanaka, T., Takemoto, K., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.162 · Cited by 43
Guo, X.-H. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1103214 · Cited by 33
GLP-1 increases Kiss-1 mRNA expression in kisspeptin-expressing neuronal cells†
Oride, A., Kanasaki, H., Mijiddorj, T., Sukhbaatar, U., Hara, T., Tumurbaatar, T., & Kyo, S. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox087 · Cited by 42
Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones
Ahmed∥, M., & Ahmed, S. (2019) · Gastroenterology Research · doi:10.14740/gr1219 · Cited by 40
Feinle, C., O'Donovan, D., & Horowitz, M. (2002) · Nutrition Reviews · doi:10.1301/002966402320243241 · Cited by 36
BATAILLE, D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0167-4 · Cited by 40
The Pancreatic β-Cell: The Perfect Redox System
Ježek, P., Holendová, B., Jabůrek, M., Tauber, J. A., Dlasková, A., & Plecitá‐Hlavatá, L. (2021) · Antioxidants · doi:10.3390/antiox10020197 · Cited by 46
Incretin hormone expression in the gut of diabetic mice and rats
Berghöfer, P., Peterson, R. G., Schneider, K., Fehmann, H. C., & Göke, B. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90251-1 · Cited by 39
Self-citationLaesser, C. I., Cumming, P., Reber, E., Stanga, Z., Muka, T., & Bally, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070935 · Cited by 36
“…these patients due to one or more of the following factors: (1) diminished insulin sensitivity due to inflammation, stress hormones, and sedentarism [5]; (2) increased carbohydrate provision [6]; and (3) side-e ff ects of medication such as glucocorticoids that interfere with glucose metabolism [7].”
InfluentialBowels control brain: gut hormones and obesity
Bewick, G. A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.032 · Cited by 36
Heidari, A. (2020) · Advanced Science Engineering and Medicine · doi:10.1166/asem.2020.2635 · Cited by 38
Hosaka, H., Kusano, M., Zai, H., Kawada, A., Kuribayashi, S., Shimoyama, Y., Nagoshi, A., Maeda, M., Kawamura, O., & Mori, M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12050 · Cited by 36
Shao, Y., Yuan, G., Zhang, J., & Guo, X. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s79175 · Cited by 33
Shimotoyodome, A., Fukuoka, D., Suzuki, J. S., Fujii, Y., Mizuno, T., Meguro, S., Tokimitsu, I., & Hase, T. (2009) · Endocrinology · doi:10.1210/en.2008-1162 · Cited by 37
Lu, W. J., Yang, Q., Sun, W. Y., Woods, S. C., D’Alessio, D. A., & Tso, P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2007 · Cited by 39
Giblett, J. P., Clarke, S. J., Dutka, D. P., & Hoole, S. P. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.011 · Cited by 35
Bariatric surgery and hypertension
Bueter, M., Ahmed, A., Ashrafian, H., & le Roux, C. W. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.03.218 · Cited by 44
Jejunal Leptin-PI3K Signaling Lowers Glucose Production
Rasmussen, B. A., Breen, D. M., Duca, F. A., Côté, C. D., Zadeh‐Tahmasebi, M., Filippi, B., & Lam, T. K. T. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.014 · Cited by 37
Effects and Mechanisms of Vagal Nerve Stimulation on Body Weight in Diet-Induced Obese Rats
Dai, F., Yin, J., & Chen, J. D. Z. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04365-7 · Cited by 36
Paschetta, E., Hvalryg, M., & Musso, G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00897.x · Cited by 32
Radulescu, A., Gannon, M. C., & Nuttall, F. Q. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2559 · Cited by 34
Tang, S., & Sambanis, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00399-1 · Cited by 37
Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers
Winzeler, B., da Conceição, I., Refardt, J., Sailer, C. O., Dutilh, G., & Christ-Crain, M. (2020) · Endocrine · doi:10.1007/s12020-020-02394-2 · Cited by 33
Incretin and Islet Hormone Responses to Meals of Increasing Size in Healthy Subjects
Alsalim, W., Omar, B., Pacini, G., Bizzotto, R., Mari, A., & Ahrén, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2865 · Cited by 33
“The increase in incretin hormones by increased meal size might be explained by an increased nutrient exposure of K cells and L cells in the intestinal mucosa because both cells have been shown to respond to luminal carbohydrate, fat, and protein (23, 25).”
BackgroundRole of gastrointestinal hormones in feeding behavior and obesity treatment
Kairupan, T. S., Amitani, H., Cheng, K., Runtuwene, J., Asakawa, A., & Inui, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1118-4 · Cited by 41
Feng, J., Kang, C., Wang, C., Ding, L., Zhu, W., & Hang, S. (2019) · Animals · doi:10.3390/ani9080476 · Cited by 35
The Role of the Bacterial Muramyl Dipeptide in the Regulation of GLP-1 and Glycemia
Williams, L., Alshehri, A., Robichaud, B., Cudmore, A. O., & Gagnon, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155252 · Cited by 33
Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity
Field, B. C. T., Wren, A., Cooke, D., & Bloom, S. R. (2008) · Drugs · doi:10.2165/00003495-200868020-00002 · Cited by 38
Mechanism of glucagon-like peptide 1 improvements in type 2 diabetes mellitus and obesity.
Nolen-Doerr, E., Stockman, M.-C., & Rizo, I. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00350-4 · Cited by 32
Hopkins, M., Beaulieu, K., Myers, A., Gibbons, C., & Blundell, J. E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1395693 · Cited by 36
The Gut–Brain Axis and Its Role in Controlling Eating Behavior in Intestinal Inflammation
Moran, G. W., & Thapaliya, G. (2021) · Nutrients · doi:10.3390/nu13030981 · Cited by 33
Dalgaard, M., Thomsen, C., Rasmussen, B. M., Holst, J. J., & Hermansen, K. (2003) · Metabolism · doi:10.1016/j.metabol.2003.08.011 · Cited by 34
Shah, F. A., Mahmud, H., Gallego‐Martin, T., Jurczak, M. J., O'Donnell, C. P., & McVerry, B. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00296 · Cited by 33
Glucagon-like peptide 1 (GLP-1) and metabolic diseases
Rotella, C. M., Pala, L., & Mannucci, E. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347560 · Cited by 35
Chaikomin, R., Wu, K., Doran, S., Meyer, J. H., Jones, K. L., Feinle‐Bisset, C., Horowitz, M., & Rayner, C. K. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.02.006 · Cited by 36
Puddu, A., Mach, F., Nencioni, A., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/591056 · Cited by 35
Smeets, A. J. P. G., Lejeune, M. P. G. M., & Westerterp‐Plantenga, M. S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508079592 · Cited by 32
Emerging role of GLP-1 receptor agonists in the treatment of obesity
Neff, L. M. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s6816 · Cited by 36
Urita, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.3092 · Cited by 31
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
Brandt, A., Katschinski, M., Arnold, R., Polonsky, K. S., Göke, B., & Byrne, M. M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e242 · Cited by 32
Self-citationFernández‐García, J. C., Murri, M., Coín‐Aragüez, L., Alcaide, J., Bekay, R. E., & Tinahones, F. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12221 · Cited by 34
Seino, Y., Maekawa, R., Ogata, H., & Hayashi, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12449 · Cited by 30
Tilinca, M. C., Tiucă, R. A., Niculas, C., Varga, A., & Ţilea, I. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10601 · Cited by 32
Alsalim, W., Lindgren, O., & Åhrén, B. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13962 · Cited by 30
Paradoxical second-meal phenomenon in the acute postexercise period
Gonzalez, J. T. (2013) · Nutrition · doi:10.1016/j.nut.2013.12.001 · Cited by 33
Gentilcore, D., Vanis, L., Wishart, J., Rayner, C. K., Horowitz, M., & Jones, K. L. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr086 · Cited by 30
Makris, A., Borradaile, K. E., Oliver, T. L., Cassim, N. G., Rosenbaum, D. L., Boden, G. H., Homko, C. J., & Foster, G. D. (2011) · Obesity · doi:10.1038/oby.2011.145 · Cited by 35
Uehara, S., Jung, S.-K., Morimoto, R., Arioka, S., Miyaji, T., Juge, N., Hiasa, M., Shimizu, K., Ishimura, A., Otsuka, M., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03575.x · Cited by 35
Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum
Herrmann-Rinke, C., Hörsch, D., McGregor, G. P., & Göke, B. (1996) · Peptides · doi:10.1016/0196-9781(96)00072-1 · Cited by 37
Self-citationMa, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.009 · Cited by 35
Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia
Byrne, Pluntke, Wank, Schirra, Arnol'd, �. �., Göke, & Katschinski (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00240.x · Cited by 31
Effects of a Preload on Reduction of Food Intake by GLP-1 in Healthy Subjects
Degen, L. P., Oesch, S., Matzinger, D., Drewe, J., Knupp, M., Zimmerli, F., & Beglinger, C. (2006) · Digestion · doi:10.1159/000097585 · Cited by 29
Gut peptides in the treatment of diabetes mellitus
Vahl, T. P., & D’Alessio, D. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.3.177 · Cited by 31
Iritani, N., Sugimoto, T., Fukuda, H., Komiya, M., & Ikeda, H. (1999) · Journal of Nutrition · doi:10.1093/jn/129.1.46 · Cited by 29
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake
Schalla, M. A., Taché, Y., & Stengel, A. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200007 · Cited by 30
The physiology and pharmacology of incretins in type 2 diabetes mellitus
Holst, J. J. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00920.x · Cited by 28
Exendin-4, a GLP-1 Receptor Agonist, Modulates the Effect of Macronutrients on Food Intake by Rats
Aziz, A. A., & Anderson, G. H. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.990 · Cited by 32
Shen, C., Fagan, S. P., Fischman, A. J., Carter, E. E., Chai, J., Lu, X.-M., Yu, Y., & Tompkins, R. G. (2011) · Surgery · doi:10.1016/j.surg.2010.11.017 · Cited by 28
O'Harte, F. P. M., Mooney, M., Kelly, C., McKillop, A. M., & Flatt, P. R. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00125-7 · Cited by 27
Glycemic Management of Hospitalized Patients Receiving Nutrition Support
Polavarapu, P., Pachigolla, S., & Drincic, A. (2022) · Diabetes Spectrum · doi:10.2337/dsi22-0010 · Cited by 29
Glycemic response to carbohydrate and the effects of exercise and protein
Roberts, S., Desbrow, B., Grant, G. D., Anoopkumar‐Dukie, S., & LEVERITT, M. D. (2013) · Nutrition · doi:10.1016/j.nut.2012.12.022 · Cited by 34
Contributions of fat and protein to the incretin effect of a mixed meal
Carrel, G., Egli, L., Tran, C., Schneiter, P., Giusti, V., D’Alessio, D. A., & Tappy, L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.017574 · Cited by 28
Amouyal, C., & Andreelli, F. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5908656 · Cited by 25
Bendet, N., Scapa, E. F., Cohen, O., Bloch, O., Aharoni, D., Ramot, Y., Weiss, M., Halevi, A., & Rapoport, M. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004839 · Cited by 27
Metadata
- Authors
- Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B.
- Affiliations
- Philipps University of Marburg (DE)
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2009-02-05
- Volume
- 56
- Issue
- 2
- Pages
- 117-126
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2064492226
- Cited by
- 597
- References
- 0
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 17 · 2023: 23 · 2022: 19 · 2021: 24 · 2020: 18 · 2019: 23 · 2018: 22 · 2017: 22 · 2016: 13 · 2015: 20 · 2014: 26 · 2013: 39 · 2012: 32
- FWCI
- 27.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Digestion (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, GLP-1 secretion, GIP secretion, postprandial hormone release, nutrient stimulation, oral glucose, intraduodenal glucose infusion, amino acids, galactose, insulin secretion
- MeSH terms
- Insulin Secretion, Adult, Amino Acids, Animals, Diet, Glucagon-Like Peptides, Fats, Food, Galactose, Glucagon, Glucose, Humans, Insulin, Male, Peptide Fragments, Peptides, Protein Precursors, Rats, Wistar, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.